Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$2.61 - $4.49 $39,150 - $67,350
15,000 New
15,000 $42,000
Q4 2021

Feb 08, 2022

SELL
$9.02 - $13.5 $1.95 Million - $2.91 Million
-215,891 Closed
0 $0
Q3 2021

Nov 02, 2021

SELL
$13.71 - $17.18 $110,680 - $138,694
-8,073 Reduced 3.6%
215,891 $3.07 Million
Q2 2021

Aug 11, 2021

BUY
$14.92 - $23.23 $1.44 Million - $2.24 Million
96,475 Added 75.67%
223,964 $3.72 Million
Q1 2021

May 14, 2021

BUY
$7.33 - $21.06 $934,494 - $2.68 Million
127,489 New
127,489 $2.32 Million

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $437M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.